PursueCare, a company that provides personalized virtual addiction treatment, announced the re-release of FDA-cleared RESET and RESET-O, prescription digital therapeutics (PDTs) for substance use disorder and opioid use disorder, respectively.
RESET and RESET-O were initially developed and commercialized by Pear Therapeutics, which filed for Chapter 11 bankruptcy last year. PursueCare acquired...
Pear Therapeutics is launching a program to offer its prescription digital therapeutics for substance use disorder and opioid use disorder, reSET and reSET-O, via telehealth providers.
The first telehealth offering working with the prescription digital therapeutic company is PursueCare, which focuses on addiction medicine.
"We find patients are often required to piece together their treatment...
